Key Record Dates Identifier: NCT02756611
Brief Title: A Study to Evaluate the Efficacy of Venetoclax in Relapsed/Refractory Participants With Chronic Lymphocytic Leukemia (CLL) Including Those With 17p Deletion or TP53 Mutation or Those Who Have Received a Prior B-cell Receptor Inhibitor. (VENICE I)

First Submitted : April 26, 2016
First Submitted that Met QC Criteria : April 27, 2016
First Posted : April 29, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : December 14, 2018
Last Update Posted : December 18, 2018 (Estimate)